Edwards Lifesciences Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	4,175	1,402	1,522	1,503
Depreciation & Amortization	155.2	144.9	139.6	134.8
Loss (Gain) From Sale of Assets	-3,348	-	-	-
Asset Writedown & Restructuring Costs	-	-	55.1	4
Loss (Gain) From Sale of Investments	-5.2	0.1	51.5	-36.8
Stock-Based Compensation	162.3	139.4	126.8	109.3
Other Operating Activities	-337.1	-264.7	-255.3	-127.6
Change in Accounts Receivable	121.2	-141.2	-84.1	-91.1
Change in Inventory	-256.1	-289	-213.4	19
Change in Accounts Payable	89.5	146	-21.4	195.2
Change in Income Taxes	-186.7	-5.8	-5.6	62
Change in Other Net Operating Assets	-27.2	-236.3	-96.9	-39.8
Operating Cash Flow	542.3	895.8	1,218	1,732
Operating Cash Flow Growth	-39.46%	-26.46%	-29.67%	64.29%
Capital Expenditures	-252.4	-253	-244.6	-325.8
Cash Acquisitions	-1,062	-95.2	-	-
Divestitures	3,927	-	-	-
Sale (Purchase) of Intangibles	-30	-13.3	-20.2	-4
Investment in Securities	-88.2	640.3	689.8	-1,350
Other Investing Activities	-182.1	-105	-172.7	-42.6
Investing Cash Flow	2,313	173.8	252.3	-1,723
Long-Term Debt Issued	-	-	-	5.2
Long-Term Debt Repaid	-	-	-	-7
Net Debt Issued (Repaid)	-	-	-	-1.8
Issuance of Common Stock	179.5	169.9	146.4	158.6
Repurchase of Common Stock	-1,159	-879.6	-1,727	-512.8
Other Financing Activities	-3.1	-1.3	-3.8	-0.3
Financing Cash Flow	-983	-711	-1,585	-356.3
Foreign Exchange Rate Adjustments	38.6	16.8	19.2	13.9
Net Cash Flow	1,911	375.4	-94.8	-332.8
Free Cash Flow	289.9	642.8	973.6	1,406
Free Cash Flow Growth	-54.90%	-33.98%	-30.77%	117.26%
Free Cash Flow Margin	5.33%	12.83%	21.81%	26.88%
Free Cash Flow Per Share	0.48	1.05	1.56	2.23
Cash Interest Paid	19.6	19.9	19.3	20.2
Cash Income Tax Paid	1,166	444.9	466.7	182.5
Levered Free Cash Flow	1,351	589.83	776.73	1,009
Unlevered Free Cash Flow	1,363	600.83	788.73	1,020
Change in Working Capital	-259.3	-526.3	-421.4	145.3

Source: S&P Global Market Intelligence. Standard template. Financial Sources.